Home
>
National Drug Code (NDC)
>
REMICADE
REMICADE - 57894-030-01 - (infliximab)
Drug Information of REMICADE
| Product NDC: | 57894-030 |
| Proprietary Name: | REMICADE |
| Non Proprietary Name: | infliximab |
| Active Ingredient(s): | 100 mg/10mL & nbsp; infliximab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of REMICADE
| Product NDC: | 57894-030 |
| Labeler Name: | Janssen Biotech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103772 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19980824 |
Package Information of REMICADE
| Package NDC: | 57894-030-01 |
| Package Description: | 10 VIAL, SINGLE-USE in 1 BOX (57894-030-01) > 10 mL in 1 VIAL, SINGLE-USE |
NDC Information of REMICADE
| NDC Code | 57894-030-01 |
| Proprietary Name | REMICADE |
| Package Description | 10 VIAL, SINGLE-USE in 1 BOX (57894-030-01) > 10 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 57894-030 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | infliximab |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19980824 |
| Marketing Category Name | BLA |
| Labeler Name | Janssen Biotech, Inc. |
| Substance Name | INFLIXIMAB |
| Strength Number | 100 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
